https://scholars.lib.ntu.edu.tw/handle/123456789/494983
標題: | 138PD: Impact of dose adjustment on the safety and efficacy of afatinib in patients (pts) with advanced EGFR mutation-positive non-small cell lung cancer (NSCLC): Post-hoc analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6) | 作者: | Schuler M CHIH-HSIN YANG Sequist L.V Yamamoto N Zhou C O'Byrne K Hirsh V Mok T Shah R Wu Y.-L. |
公開日期: | 2016 | 出版社: | Elsevier Inc | 卷: | 11 | 期: | 4 | 起(迄)頁: | S116-S117 | 來源出版物: | Journal of Thoracic Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042426881&doi=10.1016%2fS1556-0864%2816%2930248-9&partnerID=40&md5=2306ac7ebce5cd20a3a582fccb497492 https://scholars.lib.ntu.edu.tw/handle/123456789/494983 |
ISSN: | 1556-0864 | DOI: | 10.1016/S1556-0864(16)30248-9 | SDG/關鍵字: | afatinib; epidermal growth factor receptor; acne; advanced cancer; Article; controlled study; diarrhea; drug blood level; drug dose reduction; drug efficacy; drug safety; drug tolerability; EGFR gene; gene mutation; human; major clinical study; nail disease; non small cell lung cancer; post hoc analysis; priority journal; progression free survival; rash; stomatitis; unspecified side effect |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。